Oncology & Cancer

Genetic modifier affects colon tumor formation

(Medical Xpress)—Unexpected results from an ongoing experiment in the lab of Kristi Neufeld, co-leader of the Cancer Biology Program at the University of Kansas Cancer Center, led to a potentially important discovery that ...

Oncology & Cancer

Gobbling up poison: A method for killing colon cancer

These days, cancer researchers aim to design targeted and specific therapy – those that kill cancer but spare the surrounding tissue. Immunotoxins, which use cancer-targeted antibodies linked to deadly toxins such as ricin, ...

Oncology & Cancer

Research offers insight into cellular biology of colorectal cancer

A study recently published in the journal Carcinogenesis by researchers at the University of Kansas shows a new role for the protein adenomatous polyposis coli (APC) in suppressing colorectal cancer—the second-leading cause ...

Oncology & Cancer

FDA clears Avastin for late-stage cervical cancer

The Food and Drug Administration has approved Genentech's Avastin for a new use against late-stage cervical cancer, the sixth indication for the blockbuster biotech drug.

Oncology & Cancer

A possible pathway for inhibiting liver and colon cancer is found

A group of scientists from Spain, the UK and the United States has revealed the structure of a protein complex involved in liver and colon cancers. Both of these types of cancer are of significant social and clinical relevance ...

page 22 from 38